Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
Hong Kong · Delayed Price · Currency is HKD 8.11
+0.69 (9.30%)
Aug 29, 2025, 4:08 PM HKT
HKG:1167 Revenue
In the year 2024, Jacobio Pharmaceuticals Group had annual revenue of 155.71M CNY with 145.13% growth. Jacobio Pharmaceuticals Group had revenue of 155.71M in the half year ending December 31, 2024, with 279.23% growth.
Revenue
155.71M CNY
Revenue Growth
+145.13%
P/S Ratio
35.31
Revenue / Employee
605.87K CNY
Employees
257
Market Cap
5.85B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 155.71M | 92.19M | 145.13% |
| Dec 31, 2023 | 63.52M | -32.23M | -33.66% |
| Dec 31, 2022 | 95.75M | -57.06M | -37.34% |
| Dec 31, 2021 | 152.81M | -333.48M | -68.58% |
| Dec 31, 2020 | 486.29M | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 35.81B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| JD Health International | 71.34B |
| Innovent Biologics | 10.03B |
| Akeso | 2.75B |
| Sino Biopharmaceutical | 33.49B |
| WuXi Biologics | 21.98B |
| CSPC Pharmaceutical Group | 28.49B |